We are excited to announce that NBE-Therapeutics will be attending the World ADC London 2026, taking place from 23 - 26 February in London. This premier global platform for antibody-drug conjugates (ADCs) brings together leading scientists, researchers, clinicians, and industry experts from around the world.
The World ADC London conference provides a unique opportunity for us to connect, collaborate, and exchange valuable insights on the latest advancements in ADC research and development. As a company committed to innovation in oncology and beyond, we are eager to actively participate in meaningful discussions, share our expertise, and engage with the vibrant ADC community throughout the event.
We look forward to meeting you there and exploring how we can shape the future of ADCs together!
Please find more information at the following link.
NBE-Therapeutics is delighted to be part of Swiss Biotech Day 2026, happening on 4 - 5 May in Basel. This renowned event serves as a key gathering point for the global biotech community, bringing together visionaries, innovators, and leaders to shape the future of the industry.
As a company deeply committed to advancing oncology and biotechnology, we see this event as an incredible opportunity to engage with like-minded professionals, exchange groundbreaking ideas, and explore new possibilities for collaboration. Swiss Biotech Day provides the perfect setting to showcase our dedication to driving innovation and making a meaningful impact in the biotech space.
We can’t wait to connect with you in Basel and discuss how we can work together to push the boundaries of biotechnology.
To learn more about the event, visit the link.
We are excited to announce that NBE-Therapeutics will be attending the ASCO Annual Meeting, taking place in Chicago from 29 May to 2 June 2026. This renowned event brings together the brightest minds in oncology, and we are proud to be part of this global gathering of innovation and collaboration.
Don’t miss the opportunity to connect with us and other leading experts in the field at the ASCO Annual Meeting. Together, we can drive progress and explore new possibilities in cancer care and treatment.
Save the dates and join us in Chicago for what promises to be an inspiring and impactful experience!
For more information about the event, please visit the link below.
We are delighted to announce that NBE-Therapeutics will be attending the esteemed AACR Annual Meeting, taking place in San Diego from 17 -22 April 2026. This premier event gathers leading experts, researchers, and innovators in the field of cancer research, and we are honored to be part of this inspiring community.
Our team is looking forward to engaging in thought-provoking discussions, sharing insights, and exploring the latest advancements and breakthroughs in oncology. At Boehringer Ingelheim, we are committed to fostering collaboration and driving innovation to improve outcomes for patients worldwide.
We are excited about the opportunity to connect with you and explore new possibilities for advancing cancer research together. Stay tuned for more updates as we prepare for this impactful event!
Please use this link to access the information.
We are thrilled to announce that NBE-Therapeutics will be attending the Antibody Engineering & Therapeutics Europe 2026 event, taking place 27-29 May in Basel. This renowned conference serves as a key platform for the global antibody engineering and therapeutics community, bringing together leading scientists, researchers, and industry experts.
The event offers an excellent opportunity to exchange insights, explore the latest advancements, and foster collaborations in antibody engineering and therapeutic development. As a company dedicated to advancing science and improving patient outcomes, we are excited to contribute to the discussions and innovations shaping this field.
We hope to see you in Basel!
For more information about the conference, click the link below.
We are excited to announce that NBE-Therapeutics will be attending the annual ESMO Congress in Madrid, taking place from 23 – 27 October 2026. This highly influential global oncology platform brings together clinicians, researchers, patient advocates, journalists, and healthcare industry representatives from all over the world.
This presents a fantastic opportunity for us to connect, learn, and exchange valuable insights regarding the most recent advancements in our field. We are highly enthusiastic about actively participating in meaningful exchanges and engaging in insightful discussions throughout the event.
Visit the ESMO Congress 2026 website to find more details about the event.